Who are Renovoderm's investors?

Renovoderm's investors include Monte Carlo Capital.

How much funding has Renovoderm raised?

Renovoderm has disclosed $1M raised across 3 rounds.

Where is Renovoderm headquartered?

Renovoderm is headquartered in Columbus, US.

Renovoderm

Columbus, US · Founded 2016 · Delaware LLC · 1 known investors

RenovoDerm is a life sciences company developing wound care and tissue technology platforms within the medtech and biotech sectors. It operates as a commercial subsidiary of Paragen Technologies.

BiotechHealthtechMedical DevicesNew Materials

Founders & leadership

Ronald BrackenChief Executive Officer

Rodolfo BellesiNamed on SEC filing

Flavio LobatoNamed on SEC filing

Ross KayuhaNamed on SEC filing

Mario LonghiNamed on SEC filing

Hilary DixonChief Commercial Officer

Investors · 1

Monte Carlo Capital$350K – $1.5Mvia Ian Sosso · inferred

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 3 rounds · 2021–2024

▶$275KraisedMay 2024 · 6 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Robert LeeDirector
David MoritzDirector
Ronald BrackenExecutive Officer, Director

Offering amount: $2M
Amount sold: $275K
First sale: Jan 2023
Incorporated: Limited Liability Company, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$250KraisedMay 2024 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Ronald BrackenExecutive Officer, Director
Robert LeeDirector
David MoritzDirector

Offering amount: $500K
Amount sold: $250K
First sale: May 2024
Incorporated: Limited Liability Company, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$500KraisedJan 2021 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Rodolfo BellesiDirector
Flavio LobatoDirector
Ronald BrackenExecutive Officer, Director
Ross KayuhaDirector
Mario LonghiDirector

Offering amount: $1M
Amount sold: $500K
First sale: Jan 2021
Incorporated: Limited Liability Company, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Organogenesis36 shared keywordsOrganogenesis develops and manufactures regenerative medicine products, including FDA-approved skin substitutes with living cells (such as Apligraf) used to treat diabetic foot ulcers and venous leg ulcers. Its portfolio spans advanced wound care, surgery, and sports medicine, serving clinicians and patients, with manufacturing and R&D facilities in Smithfield, Rhode Island.

Globus Medical20 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.

Smith+Nephew16 shared keywordsSmith+Nephew is a medical technology company that develops products for the repair, regeneration and replacement of soft and hard tissue, operating through three business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It serves healthcare professionals and surgeons with implants, robotics-assisted surgical systems, arthroscopic technologies and wound care products across roughly 100 countries.

Companies competing with Renovoderm for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Renovoderm do?: RenovoDerm is a life sciences company developing wound care and tissue technology platforms within the medtech and biotech sectors. It operates as a commercial subsidiary of Paragen Technologies.
Who are Renovoderm's investors?: Renovoderm's investors include Monte Carlo Capital.
How much funding has Renovoderm raised?: Renovoderm has disclosed $1M raised across 3 rounds.
Where is Renovoderm headquartered?: Renovoderm is headquartered in Columbus, US.